DeepScribe vs Marvix AI (2026)

AI Health Index verifiedAugust 4, 2026
Verdict

Both reject the assumption that a scribe should be tuned for a fifteen minute primary care visit, and they specialise differently. DeepScribe concentrates on oncology and a handful of adjacent specialties, reports documenting a very large share of United States cancer care visits, and holds the strongest independent buyer rating in this category with genuinely bidirectional integration that reads the chart before the visit and writes structured data back after. Marvix spreads wider across specialty care, built for long consults and complex longitudinal histories with named two way integrations. For an oncology service, DeepScribe has the depth and the references. For a multi specialty group, Marvix covers more without pretending a single model fits every visit. The gap to close on DeepScribe is retention, since its policy permits keeping personal data beyond the term of the relationship.

The case for DeepScribe
  • Specialty depth is the design centre rather than a claim, aimed at long consults, complex histories and longitudinal care with a very large stated specialty range.
  • Integrations are named, broad and genuinely two way, and the vendor names its techniques rather than gesturing at them.
  • For a specialty group whose visits do not resemble a short primary care encounter, a product built for that shape needs less correction.
The case for Marvix AI
  • Specialty tuning is stated as a deliberate focus with a concentration in oncology, reporting a very large share of United States cancer care visits documented on the platform.
  • The integration is genuinely bidirectional, reading problems, medications, labs and prior notes before the encounter and writing structured data back afterwards.
  • The strongest independent buyer rating in this category, with top marks across all measured categories in a survey based assessment.

This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. DeepScribe and Marvix AI are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded

At a Glance

Plain facts

Fact DeepScribe Marvix AI
Primary category Ambient Scribes Ambient Scribes
Founded 2017 2023
Headquarters San Francisco, California Boston, Massachusetts
Website deepscribe.ai marvix.ai
Attribute Matrix

Side by Side

Axis
D
DeepScribe
M
Marvix AI
AI Centrality
Autonomy and Oversight Model
Model and Technology Transparency
Model Supply Chain Disclosure
Clinical and Operational Evidence
AI Safety and PHI Stewardship
HIPAA and BAA Posture
Security Certifications and Trust Center
FDA and Regulatory Status
AI Governance and Bias Disclosure
AI Liability and Recourse
EHR and Interoperability Depth
Deployment Model and Data Residency
Commercial Transparency
Setting and Specialty Coverage
Citable Summaries

Each record in one paragraph

Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.

DeepScribe

The AI Health Index awards DeepScribe its top capability grade on several axes, including AI Centrality, Clinical and Operational Evidence and HIPAA and BAA Posture. Set against Marvix AI, DeepScribe grades higher on Clinical and Operational Evidence, HIPAA and BAA Posture and FDA and Regulatory Status. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.

Source: AI Health Index, August 2026

Marvix AI

The AI Health Index awards Marvix AI its top capability grade on AI Centrality, EHR and Interoperability Depth and Setting and Specialty Coverage. Set against DeepScribe, Marvix AI grades higher on Model and Technology Transparency, AI Safety and PHI Stewardship and Security Certifications and Trust Center. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.

Source: AI Health Index, August 2026

FAQ

Questions buyers ask

Should we choose DeepScribe or Marvix AI?

On the axes where the AI Health Index separates them, DeepScribe grades higher on Clinical and Operational Evidence, HIPAA and BAA Posture and FDA and Regulatory Status, and Marvix AI grades higher on Model and Technology Transparency, AI Safety and PHI Stewardship and Security Certifications and Trust Center. Neither leads on the greater share of scored axes, so the decision turns on which constraint is binding rather than on an overall winner.

Where do DeepScribe and Marvix AI differ most?

The widest separation the AI Health Index records between DeepScribe and Marvix AI is on Clinical and Operational Evidence, where DeepScribe grades A and Marvix AI grades C. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.

Where do DeepScribe and Marvix AI grade the same?

The AI Health Index grades DeepScribe and Marvix AI the same on several axes, including AI Centrality, Autonomy and Oversight Model and Model Supply Chain Disclosure. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.

Keep Comparing

Related comparisons

Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Ambient Scribes page.

Disclosure

DeepScribe's published privacy policy permits retaining personal data as long as it remains necessary, potentially beyond the term of the relationship, which is the weakest retention position recorded in this index for a product that records patient encounters, and its security page claims relevant certifications without naming one. Marvix publishes no rate card, hosting region or residency option, and no study, benchmark or named deployment was located. Both market improved coding capture alongside documentation, so ask each for its add to delete ratio and what proportion of suggested codes survive audit.